I think it is important that there be transparency about what it is that causes an FSOC designation.
Editor's note · Context
Warren emphasizes the need for transparency in FSOC designations.
Share
More from Elizabeth Warren
We need more visibility into what’s happening in these transactions when it has the potential to influence such an important part of our pharmaceutical chain.
A Paramount-Warner Bros. megamerger would mean higher costs and fewer choices for Americans. Good news: the states are stepping up to block this antitrust nightmare. This fight isn’t over.
Trump refused to sign it, but he couldn’t stop it. This law is groundbreaking. It will build more housing, bring down costs, and for the first time, stop private equity from buying up homes.
Without greater visibility into these acquisitions, it is not just national security that could be on the line — Americans’ access to medicines is also at risk.





